Title |
Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary
|
---|---|
Published in |
Theoretical Biology and Medical Modelling, November 2008
|
DOI | 10.1186/1742-4682-5-24 |
Pubmed ID | |
Authors |
Kenneth Blum, Amanda LihChuan Chen, Thomas JH Chen, Eric R Braverman, Jeffrey Reinking, Seth H Blum, Kimberly Cassel, Bernard W Downs, Roger L Waite, Lonna Williams, Thomas J Prihoda, Mallory M Kerner, Tomas Palomo, David E Comings, Howard Tung, Patrick Rhoades, Marlene Oscar-Berman |
Abstract |
Based on neurochemical and genetic evidence, we suggest that both prevention and treatment of multiple addictions, such as dependence to alcohol, nicotine and glucose, should involve a biphasic approach. Thus, acute treatment should consist of preferential blocking of postsynaptic Nucleus Accumbens (NAc) dopamine receptors (D1-D5), whereas long term activation of the mesolimbic dopaminergic system should involve activation and/or release of Dopamine (DA) at the NAc site. Failure to do so will result in abnormal mood, behavior and potential suicide ideation. Individuals possessing a paucity of serotonergic and/or dopaminergic receptors, and an increased rate of synaptic DA catabolism due to high catabolic genotype of the COMT gene, are predisposed to self-medicating any substance or behavior that will activate DA release, including alcohol, opiates, psychostimulants, nicotine, gambling, sex, and even excessive internet gaming. Acute utilization of these substances and/or stimulatory behaviors induces a feeling of well being. Unfortunately, sustained and prolonged abuse leads to a toxic" pseudo feeling" of well being resulting in tolerance and disease or discomfort. Thus, a reduced number of DA receptors, due to carrying the DRD2 A1 allelic genotype, results in excessive craving behavior; whereas a normal or sufficient amount of DA receptors results in low craving behavior. In terms of preventing substance abuse, one goal would be to induce a proliferation of DA D2 receptors in genetically prone individuals. While in vivo experiments using a typical D2 receptor agonist induce down regulation, experiments in vitro have shown that constant stimulation of the DA receptor system via a known D2 agonist results in significant proliferation of D2 receptors in spite of genetic antecedents. In essence, D2 receptor stimulation signals negative feedback mechanisms in the mesolimbic system to induce mRNA expression causing proliferation of D2 receptors. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Portugal | 2 | <1% |
Netherlands | 2 | <1% |
Italy | 1 | <1% |
Brazil | 1 | <1% |
United Kingdom | 1 | <1% |
Iran, Islamic Republic of | 1 | <1% |
Spain | 1 | <1% |
United States | 1 | <1% |
Unknown | 196 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 39 | 19% |
Researcher | 32 | 16% |
Student > Master | 24 | 12% |
Student > Bachelor | 20 | 10% |
Student > Doctoral Student | 12 | 6% |
Other | 38 | 18% |
Unknown | 41 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Psychology | 51 | 25% |
Medicine and Dentistry | 46 | 22% |
Agricultural and Biological Sciences | 17 | 8% |
Neuroscience | 16 | 8% |
Nursing and Health Professions | 7 | 3% |
Other | 19 | 9% |
Unknown | 50 | 24% |